机译:基于差分ER表达的海绵母乳癌不同的组织组织
Department of PathologyKurume University School of MedicineKurume Fukuoka Japan;
Department of PathologyKurume University School of MedicineKurume Fukuoka Japan;
Department of PathologyKurume University School of MedicineKurume Fukuoka Japan;
Biostatistics CentreKurume University School of MedicineKurume Fukuoka Japan;
Department of SurgeryKurume Fukuoka Japan;
Department of SurgeryKurume University School of MedicineKurume Fukuoka Japan;
Department of Diagnostic PathologyKurume University HospitalKurume Fukuoka Japan;
Biostatistics CentreKurume University School of MedicineKurume Fukuoka Japan;
Department of SurgeryKurume Fukuoka Japan;
Department of SurgeryKurume University School of MedicineKurume Fukuoka Japan;
Department of PathologyKurume University School of MedicineKurume Fukuoka Japan;
central scar; comedo necrosis; HER2‐positive breast carcinoma; oestrogen receptor; tumour‐infiltrating lymphocytes;
机译:基于差分ER表达的海绵母乳癌不同的组织组织
机译:内源性乳酸受体GPR81在ERα阳性/ HER2阳性上皮与EMT后三阴性间充质乳腺癌细胞中的差异表达和功能
机译:nolus:一种基于雌激素受体(ER),孕酮受体(PR)和Ki67免疫组化(IHC)在激素受体阳性/ HER2阴性(HR + / HER2-)中的基于雌激素受体(ER),孕酮受体(PR)和KI67)的预测模型 乳腺癌(BC)
机译:HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关:回顾性和多中心研究
机译:分析mutp53和HER2之间的致癌合作,提出mutp53作为HER2阳性乳腺癌的生物标志物。
机译:使用综合生物信息分析鉴定ER阳性/ HER2阴性乳腺癌和ER阴性/ HER2阴性乳腺癌之间的关键差异表达基因
机译:ER阳性HER2阴性乳腺癌的基因表达特征之间的低一致性可能会损害其临床应用。